Eli Lilly, JPM, Novo Nordisk, Bain

Sign up for the biotech newsletter to stay on top of the latest science and politics driving the biotech industry. The newsletter includes previews of biotech conferences, updates on obesity drug development, and IPO filings. The need-to-know includes warnings from Eli Lilly on the use of its weight loss drugs, a judge’s recommendation to dismiss…

Read More

PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease

PharmaKure has received approval from the UK MHRA to begin a Phase 2a study for its drug PK051, intended for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s Disease. PK051 is an oral combined drug that targets the disaggregation of amyloid-β proteins, believed to be the initial event in Alzheimer’s Disease pathology. The…

Read More

What I’ve Learned About the Challenges of MG

The article discusses the challenges of MG (Myasthenia Gravis) and what the author has learned about it. It emphasizes the unpredictability of symptoms, the impact on daily life, and the difficulty of finding effective treatment. The author also highlights the importance of finding a supportive healthcare team and community. Overall, the article provides insight into…

Read More

Wybór domeny i wpływ na SEO

Podsumowując, wybór domeny ma znaczący wpływ na pozycjonowanie strony i warto dobrze przemyśleć ten wybór. Warto zwrócić uwagę na słowa kluczowe, długość domeny, rozszerzenia domen, unikalność i bezpieczeństwo adresowania stron, budowanie autorytetu marki, wiek domeny, lokalizację serwera, subdomeny, historię domeny oraz domeny związane tematycznie, międzynarodowe i eksperymentalne. Wszystkie te czynniki mogą pomóc w zbudowaniu konkurencyjnej…

Read More

From Last Resort to Mainstay: The Evolution of ECMO in Critical Care

The Wall Street Journal article discusses the ethical considerations for hospitals regarding Extracorporeal Membrane Oxygenation (ECMO) due to its increasing success rates in treating critically ill patients. The technology has greatly improved survival rates, with some cases exceeding 70%. Its efficacy has been validated by recent studies, making it comparable to other life-saving interventions like…

Read More
error: Content is protected !!